RevMedx
Wilsonville, US · Oregon corporation
RevMedx develops hemorrhage-control medical devices, including the XSTAT expanding-sponge injector for junctional bleeding, ratcheting TX tourniquets, and compression wraps. Its products serve licensed medical professionals, first responders, and military users such as US Special Operations Forces.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2016
▶$3.5MraisedMar 2016 · 2 investors · OtherRule 506(b)
▶$3.5MraisedMar 2016 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kenton W. GregoryExecutive Officer, Director
- Andrew D. BarofskyExecutive Officer, Director
- Shari D. BekeExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $3.5M
- First sale
- Feb 2016
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with RevMedx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does RevMedx do?
- RevMedx develops hemorrhage-control medical devices, including the XSTAT expanding-sponge injector for junctional bleeding, ratcheting TX tourniquets, and compression wraps. Its products serve licensed medical professionals, first responders, and military users such as US Special Operations Forces.
- How much funding has RevMedx raised?
- RevMedx has disclosed $3.5M raised across 1 round.
- Where is RevMedx headquartered?
- RevMedx is headquartered in Wilsonville, US.
